Inventor · disambiguated record
Steven Wayne Riesinger
Also filed as: RIESINGER STEVEN · RIESINGER STEVEN W · RIESINGER STEVEN WAYNE
9 granted patents·2 pending applications·12 citations·filing 2001–2024
81Inventor score
Files withBIOAXONE BIOSCIENCES INC4THE BURLINGTON HC RES GROUP INC3ENANTA PHARM INC2MEDCHEM PARTNERS LLC2
Top patents by PatentIndex Score
11 records- 0190US10149856B2Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitorsBIOAXONE BIOSCIENCES INC·Filed 2017·Granted Dec 11, 2018·6 cites·6 claims
- 0281US11554174B2Methods for improved protection and delivery of aminothiols and analogs thereofTHE BURLINGTON HC RES GROUP INC·Filed 2020·Granted Jan 17, 2023·1 cites·18 claims
- 0378US2024299409A1Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitorsBIOAXONE BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0476US10780176B2Methods for improved protection and delivery of aminothiols and analogs thereofTHE BURLINGTON HC RES GROUP INC·Filed 2016·Granted Sep 22, 2020·2 cites·1 claims
- 0574US12128107B2Methods for improved protection and delivery of aminothiols and analogs thereofTHE BURLINGTON HC RES GROUP INC·Filed 2022·Granted Oct 29, 2024·0 cites·17 claims
- 0670US10857157B2Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitorsBIOAXONE BIOSCIENCES INC·Filed 2018·Granted Dec 8, 2020·0 cites·14 claims
- 0768US11701366B2Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitorsBIOAXONE BIOSCIENCES INC·Filed 2020·Granted Jul 18, 2023·0 cites·7 claims
- 0862US6673821B2Nitrogen heterocycle inhibitors of aspartyl proteaseENANTA PHARM INC·Filed 2001·Granted Jan 6, 2004·2 cites·4 claims
- 0954US11148999B2Nitric oxide donorsMEDCHEM PARTNERS LLC·Filed 2017·Granted Oct 19, 2021·0 cites·18 claims
- 1052US6696494B2α-hydroxyarylbutanamine inhibitors of aspartyl proteaseENANTA PHARM INC·Filed 2001·Granted Feb 24, 2004·1 cites·7 claims
- 1152US2022064106A1Nitric oxide donorsMEDCHEM PARTNERS LLC·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →